Home > Healthcare > Medical Devices > Operating Room Supplies > Fluorescence Guided Surgery Systems Market

Fluorescence Guided Surgery Systems Market Trends

Report ID: GMI9171
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Fluorescence Guided Surgery Systems Market Trends

Government initiatives aimed at improving surgical infrastructure significantly propel the demand for fluorescence guided surgery systems. These initiatives often include funding for advanced medical technologies, upgrading surgical facilities, and promoting the adoption of innovative tools to enhance surgical outcomes.

For instance, in July 2024, OnLume Inc. received a substantial USD 2 million Phase II Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH)'s National Cancer Institute (NCI).
This grant supported the advancement of OnLume's innovative FGS system. The funding aimed to facilitate further refinement of the device, enhancing intraoperative visualization of small lymphatic tissues and blood vessels, improving surgical precision and patient outcomes.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The fluorescence guided surgery systems industry was valued at around USD 101.3 million in 2023 and is estimated to grow at a 14.1% CAGR from 2024 to 2032, driven by advancements in imaging technology.

The SPY system segment dominated the market in 2023, accounting for a 38.1% share and a CAGR of 15%, due to its advanced imaging capabilities that enhance surgical precision.

U.S. dominated the North American fluorescence guided surgery systems industry with a revenue of USD 38.4 million in 2023, led by strong R&D efforts and medical technology innovation.

Key players in the market include B. Braun, Carl Zeiss, Danaher Corporation, Getinge, Hamamatsu Photonics, Intuitive Surgical, KARL STORZ, Medtronic, and Olympus Corporation.